Ethnic differences in nicotine metabolic rate among New Zealanders

New Zealand Medical Journal

Volumn 118, Issue 1227, 2005, Pages

  Lea, Rod A ^a,d   Benowitz, Neal ^b   Green, Michael ^a,d   Fowles, Jeff ^a   Vishvanath, Anasuya ^d   Dickson, Stuart ^a   Lea, Marino G ^a   Woodward, Alistair ^c   Chambers, Geoffrey K ^d   Phillips, David ^a  

^a INSTITUTE OF ENVIRONMENTAL SCIENCE AND RESEARCH   (New Zealand)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF AUCKLAND   (New Zealand)

^d VICTORIA UNIVERSITY OF WELLINGTON   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

3' HYDROXYCOTININE; COTININE; CYTOCHROME P450 2A6; NICOTINE; BIOLOGICAL MARKER; COUMARIN 7 HYDROXYLASE; COUMARIN 7-HYDROXYLASE; MIXED FUNCTION OXIDASE; UNSPECIFIC MONOOXYGENASE;

ADULT; ARTICLE; CIGARETTE SMOKING; CONTROLLED STUDY; ETHNIC DIFFERENCE; EUROPE; FEMALE; GENE FREQUENCY; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAORI; METABOLIC RATE; NEW ZEALAND; NICOTINE REPLACEMENT THERAPY; NUCLEOTIDE SEQUENCE; PREVALENCE; QUESTIONNAIRE; SMOKING CESSATION; ABORIGINE; CAUCASIAN; COMPARATIVE STUDY; ETHNOLOGY; GENETICS; METABOLISM; SALIVA; SMOKING; STATISTICS;

ARYL HYDROCARBON HYDROXYLASES; BIOLOGICAL MARKERS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; MIXED FUNCTION OXYGENASES; NEW ZEALAND; NICOTINE; OCEANIC ANCESTRY GROUP; PREVALENCE; SALIVA; SMOKING;

EID: 29844455835     PISSN: 11758716     EISSN: 11758716     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Tobacco Facts (Ministry of Health) and Public Health Association of New Zealand (Policy on Tobacco), 2003.
2. Lambe J. Smoking kills 31% of Maori. N Z Med J, 1998; 111:327.
3. Borman B, Wilson N, Maling C. Socio-demographic characteristics of New Zealand smokers: results from the 1996 census. N Z Med J. 1999;112(1101):460-3.
4. Nicotine Addiction in Britain: A report from the Tobacco Advisory Group of the Royal College of Physicians. Available online. URL: http://www.rcplondon.ac.uk/pubs/books/nicotine/ Accessed November 2005.
5. Jaakkola, M.S., et al., Determinants of salivary cotinine concentrations in Chinese male smokers. Prev Med. 2003;36:282-90.
6. Benowitz NL, Pomerleau OF, Pomerleau CS, Jacob P 3rd. Nicotine metabolite ratio as a predictor of cigarette consumption. Nicotine Tob Res. 2003;5:621-4.
7. Benowitz NL, Perez-Stable EJ, Herrera B, Jacob P 3rd. Slower metabolism and reduced intake of nicotine from cigarette smoking in Chinese-Americans. J Natl Cancer Inst. 2002;94:108-15.
8. Perez-Stable EJ, Herrera B, Jacob P 3rd, Benowitz NL. Nicotine metabolism and intake in black and white smokers. JAMA. 1998;280:152-6.
9. Benowitz NL. Nicotine addiction. Prim Care. 1999;26:611-31.
10. Nakajima, M, Kuroiwa Y, Yokoi T. Interindividual differences in nicotine metabolism and genetic polymorphisms of human CYP2A6. Drug Metab Rev. 2002;34:865-77.
11. Dempsey D, Tutka P, Jacob P, et al. Nicotine metabolite ratio as an index of CYP2A6 metabolic activity. 2004 Clin Pharmacol Ther. 2004;76:64-72.
12. Jarvis MJ, Primatesta P, Erens B, et al. Measuring nicotine intake in population surveys: comparability of saliva cotinine and plasma cotinine estimates. Nicotine Tob Res. 2003;5:349-55.
13. Swan GE, Benowitz NL, Lessov CN, et al. Nicotine metabolism: the impact of CYP2A6 on estimates of additive genetic influence. Pharmacogenet Genomics. 2005;15:115-25.
14. Malaiyandi V, Sellers EM, Tyndale RF. Implications of CYP2A6 genetic variation for smoking behaviors and nicotine dependence. Clin Pharmacol Ther. 2005;77:145-58. Review.
15. Schoedel KA, Hoffmann EB, Rao Y, et al. Ethnic variation in CYP2A6 and association of genetically slow nicotine metabolism and smoking in adult Caucasians. Pharmacogenetics. 2004;14:615-26.
16. Yoshida R, Nakajima M, Nishimura K, et al. Effects of polymolphism in promoter region of hunian CYP2A6 gene (CYP2A6*9) on expression level of messenger ribonucleic acid and enzymatic activity in vivo and in vitro. Clin Pharmacol Ther. 2003;74:69-76.
17. Chambers GK, Marshall SJ, Robinson GM, et al. The genetics of alcoholism in Polynesians: alcohol and aldehyde dehydrogenase genotypes in young men. Alcohol Clin Exp Res. 2002;26:949-55.
18. Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom KO. The Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire. Br J Addict. 1991;86:1119-27.
19. Nakajima M, Kwon JT, Tanaka N, et al. Relationship between interindividual differences in nicotine metabolism and CYP2A6 genetic polymorphism in humans. Clin Pharmacol Ther. 2001;69:72-8.
20. O'Loughlin J, Paradis G, Kim W, et al. Genetically decreased CYP2A6 and the risk of tobacco dependence: a prospective study of novice smokers. Tob Control. 2004;13:422-8.
21. Scragg R. Report of 1999-2003 National Year 10 Smoking Surveys (2004). Available online. URL: http://www.ash.org.nz/pdf/Smoking/Youth/ASH2003survey.pdf Accessed November 2005.
22. BRC Marketing and Social Research. Evaluation of the Quitline subsidised NRT exchange programme; 2004. Available online. URL: http://www.quit.org.nz/documents/EvQuitlineNRT-Pro.pdf Accessed November 2005.